Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer

被引:23
|
作者
Yang, Guoliang [1 ]
Bondaruk, Jolanta [1 ]
Cogdell, David [1 ]
Wang, Ziqiao [2 ]
Lee, Sangkyou [1 ]
Lee, June Goo [1 ]
Zhang, Shizhen [1 ]
Choi, Woonyoung [3 ]
Wang, Yan [1 ]
Liang, Yu [1 ]
Wang, Gang [1 ]
Wang, Ying [2 ]
Yao, Hui [4 ]
Dadhania, Vipulkumar [1 ]
Gao, Jianjun [5 ]
Logothetis, Christopher [5 ]
Siefker-Radtke, Arlene [5 ]
Kamat, Ashish [6 ]
Dinney, Colin [6 ]
Theodorescu, Dan [7 ]
Kimmel, Marek [8 ]
Wei, Peng [2 ]
Guo, Charles C. [1 ]
Weinstein, John N. [4 ]
McConkey, David J. [3 ]
Czerniak, Bogdan [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[3] Johns Hopkins Univ, Johns Hopkins Greenberg Bladder Canc Inst, Baltimore, MD USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[7] Cedars Sinai, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
[8] Rice Univ, Dept Stat, Houston, TX 77251 USA
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; INFILTRATING IMMUNE CELLS; MOLECULAR CLASSIFICATION; LUMINAL SUBTYPES; CARCINOMA; BREAST; EXPRESSION; BASAL; IDENTIFICATION; DYSREGULATION;
D O I
10.1016/j.isci.2020.101201
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We report a comprehensive molecular analysis of 34 cases of small cell carcinoma (SCC) and 84 cases of conventional urothelial carcinoma (UC), with The Cancer GenomeAtlas cohort of 408 conventional UCbladder cancers used as the reference. SCCs showed mutational landscapes characterized by nearly uniforminactivation of TP53 and were dominated by Sanger mutation signature 3 associated with loss of BRCA1/2 function. SCCs were characterized by downregulation of luminal and basal markers and were referred to as double-negative. Transcriptome analyses indicated that SCCs displayed lineage plasticity driven by a urothelial-to-neural phenotypic switch with a dysregulated epithelial-to-mesenchymal transition network. SCCs were depleted of immune cells, and expressed high levels of the immune checkpoint receptor, adenosine receptor A2A(ADORA2A), which is a potent inhibitor o fimmune infiltration. Our observations have important implications for the prognostication and development of more effective therapies for this lethal bladder cancer variant.
引用
收藏
页数:35
相关论文
共 50 条
  • [41] Metachronous primary urothelial carcinoma following small cell carcinoma of the urinary bladder
    Yao, Henry H. I.
    Chu, Kevin
    Hallot, Christopher
    Lewin, Jonathan
    ANZ JOURNAL OF SURGERY, 2017, 87 (1-2) : 96 - 98
  • [42] SMALL CELL CANCER WITH RARE PRESENTATION AS BLADDER CANCER
    Sultan, A.
    Ibilibor, C.
    Suarez, G.
    Shanshal, M.
    Hardwicke, F.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 562 - 562
  • [43] The First Report of Urothelial (Clear Cell Variant) Bladder Cancer in a Child
    Minkowitz, Shaul Yosef
    Wadee, Reubina
    Adam, Ahmed
    UROLOGY, 2016, 97 : 204 - 207
  • [44] Urinary bladder spindle-cell neoplasm concomitant with urothelial cancer
    Chen, Jeng-Sheng
    Shen, Cheng-Huang
    Cheng, Ming-Chin
    Lin, Chang-Te
    Jou, Yeong-Chin
    Chen, Pi-Che
    Wu, Jiann-Der
    UROLOGICAL SCIENCE, 2013, 24 (02) : 61 - 64
  • [45] High-Plasticity Cell State Drives Heterogeneity in Lung Cancer
    不详
    CANCER RESEARCH, 2020, 80 (18) : 3772 - 3772
  • [46] Plasticity of preneoplastic cells drives esophageal squamous cell cancer initiation
    Ko, Kyung Pil
    Zhang, Jie
    Jun, Sohee
    Park, Jae-Il
    CANCER RESEARCH, 2024, 84 (06)
  • [47] Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
    Raghavan, Srivatsan
    Winter, Peter S.
    Navia, Andrew W.
    Williams, Hannah L.
    DenAdel, Alan
    Lowder, Kristen E.
    Galvez-Reyes, Jennyfer
    Kalekar, Radha L.
    Mulugeta, Nolawit
    Kapner, Kevin S.
    Raghavan, Manisha S.
    Borah, Ashir A.
    Liu, Nuo
    Vayrynen, Sara A.
    Costa, Andressa Dias
    Ng, Raymond W. S.
    Wang, Junning
    Hill, Emma K.
    Ragon, Dorisanne Y.
    Brais, Lauren K.
    Jaeger, Alex M.
    Spurr, Liam F.
    Li, Yvonne Y.
    Cherniack, Andrew D.
    Booker, Matthew A.
    Cohen, Elizabeth F.
    Tolstorukov, Michael Y.
    Wakiro, Isaac
    Rotem, Asaf
    Johnson, Bruce E.
    McFarland, James M.
    Sicinska, Ewa T.
    Jacks, Tyler E.
    Sullivan, Ryan J.
    Shapiro, Geoffrey, I
    Clancy, Thomas E.
    Perez, Kimberly
    Rubinson, Douglas A.
    Ng, Kimmie
    Cleary, James M.
    Crawford, Lorin
    Manalis, Scott R.
    Nowak, Jonathan A.
    Wolpin, Brian M.
    Hahn, William C.
    Aguirre, Andrew J.
    Shalek, Alex K.
    CELL, 2021, 184 (25) : 6119 - +
  • [48] A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells
    Boiteux, Guillaume
    Lascombe, Isabelle
    Roche, Emmanuelle
    Plissonnier, Marie-Laure
    Clairotte, Anne
    Bittard, Hugues
    Fauconnet, Sylvie
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (08) : 1820 - 1828
  • [49] Small Cell Bladder Cancer: Biology and Management
    Fahed, Elie
    Hansel, Donna E.
    Raghavan, Derek
    Quinn, David I.
    Dorff, Tanya B.
    SEMINARS IN ONCOLOGY, 2012, 39 (05) : 615 - 618
  • [50] Genomic Characterization of Small Cell Bladder Cancer
    Czerniak, Bogdan
    Yang, Guoliang
    Bondaruk, Jolanta
    Wang, Ziqiao
    Wei, Peng
    Cogdell, David
    Yao, Hui
    Guo, Charles
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 879 - 879